糖尿病微血管并发症的新诊断与治疗方法
New Diagnostic and Therapeutic Approaches in Diabetic Microvascular Complications.
作者信息
Serban Dragos, Dascalu Ana Maria
机构信息
Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Fourth Surgery Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania.
出版信息
Biomedicines. 2024 Aug 15;12(8):1858. doi: 10.3390/biomedicines12081858.
Abstract
Diabetes mellitus is a major global health problem with an ascendant trend that makes it expected to reach up to 700 million cases by 2045 [...].
摘要
糖尿病是一个重大的全球健康问题，且呈上升趋势，预计到2045年病例数将高达7亿例[……]。
相似文献
1
New Diagnostic and Therapeutic Approaches in Diabetic Microvascular Complications.糖尿病微血管并发症的新诊断与治疗方法
Biomedicines. 2024 Aug 15;12(8):1858. doi: 10.3390/biomedicines12081858.
2
Novel therapeutic approaches for diabetic nephropathy and retinopathy.治疗糖尿病肾病和视网膜病变的新方法。
Pharmacol Res. 2015 Aug;98:39-44. doi: 10.1016/j.phrs.2014.10.003. Epub 2014 Oct 29.
3
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.糖尿病心血管并发症及事件的预防方法。
Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005.
4
Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.精氨酸脱羧酶抑制剂在 2 型糖尿病微血管并发症发病机制中的作用。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1183586. doi: 10.3389/fendo.2023.1183586. eCollection 2023.
5
Diabetic microvascular complications are associated with reduced global longitudinal strain independent of atherosclerotic coronary artery disease in asymptomatic patients with diabetes mellitus: a cross-sectional study.糖尿病患者无症状时，其微血管并发症与整体纵向应变降低相关，与动脉粥样硬化性冠状动脉疾病无关：一项横断面研究。
BMC Cardiovasc Disord. 2021 Jun 2;21(1):269. doi: 10.1186/s12872-021-02063-w.
6
Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.抗炎植物源性生物活性化合物在糖尿病微血管并发症中的潜在作用。
Molecules. 2022 Oct 29;27(21):7352. doi: 10.3390/molecules27217352.
7
A Study of the Mean Platelet Volume and Plasma Fibrinogen in Type Two Diabetes Mellitus Patients Versus Healthy Controls and Their Role as Early Markers of Diabetic Microvascular Complications.2型糖尿病患者与健康对照者的平均血小板体积和血浆纤维蛋白原研究及其作为糖尿病微血管并发症早期标志物的作用
Cureus. 2024 Jul 26;16(7):e65458. doi: 10.7759/cureus.65458. eCollection 2024 Jul.
8
[A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].一项评估1型糖尿病发病后视网膜病变和肾病发展的20年前瞻性随访研究：血糖控制和代谢记忆的作用
Ter Arkh. 2017;89(10):17-21. doi: 10.17116/terarkh2017891017-21.
9
Establishment of Zebrafish Models for Diabetes Mellitus and Its Microvascular Complications.糖尿病及其微血管并发症斑马鱼模型的建立。
J Vasc Res. 2022;59(4):251-260. doi: 10.1159/000522471. Epub 2022 Apr 4.
10
Correlation of Platelet Indices in Patients With Type 2 Diabetes Mellitus and Associated Microvascular Complications: A Hospital-Based, Prospective, Case-Control Study.2型糖尿病患者血小板指标与相关微血管并发症的相关性：一项基于医院的前瞻性病例对照研究。
Cureus. 2024 Mar 11;16(3):e55959. doi: 10.7759/cureus.55959. eCollection 2024 Mar.
本文引用的文献
1
Impact of Angiopoietin-2 on Kidney Diseases.血管生成素-2对肾脏疾病的影响。
Kidney Dis (Basel). 2023 Mar 14;9(3):143-156. doi: 10.1159/000529774. eCollection 2023 May.
2
The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management.糖尿病与肾脏疾病之间的双向联系：机制与管理
Cureus. 2023 Sep 20;15(9):e45615. doi: 10.7759/cureus.45615. eCollection 2023 Sep.
3
High Plasma Angiopoietin-2 Levels Predict the Need to Initiate Dialysis within Two Years in Patients with Chronic Kidney Disease.高血浆血管生成素-2 水平可预测慢性肾脏病患者在两年内需要开始透析。
Int J Mol Sci. 2023 Jun 12;24(12):10036. doi: 10.3390/ijms241210036.
4
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence.新冠病毒感染是否会增加患糖尿病的风险？现有证据。
Curr Diab Rep. 2023 Aug;23(8):207-216. doi: 10.1007/s11892-023-01515-1. Epub 2023 Jun 7.
5
Association of COVID-19 Infection With Incident Diabetes.COVID-19 感染与新发糖尿病的关联。
JAMA Netw Open. 2023 Apr 3;6(4):e238866. doi: 10.1001/jamanetworkopen.2023.8866.
6
Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation.糖尿病视网膜病变是失明的主要原因以及一系列并发症的早期预测指标——风险与缓解措施。
EPMA J. 2023 Feb 13;14(1):21-42. doi: 10.1007/s13167-023-00314-8. eCollection 2023 Mar.
7
The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus.血小板与淋巴细胞比值可预测2型糖尿病患者的糖尿病视网膜病变。
Diabetes Metab Syndr Obes. 2022 Nov 22;15:3617-3626. doi: 10.2147/DMSO.S378284. eCollection 2022.
8
Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients.抗血管内皮生长因子药物治疗糖尿病性黄斑水肿患者的疗效及机制
World J Diabetes. 2022 Jul 15;13(7):532-542. doi: 10.4239/wjd.v13.i7.532.
9
Macular vessel density before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者全视网膜光凝前后的黄斑血管密度
Int J Retina Vitreous. 2022 Mar 14;8(1):21. doi: 10.1186/s40942-022-00369-1.
10
Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus.近年来用于诊断和筛查 2 型糖尿病的生物标志物的研究进展。
Curr Diab Rep. 2022 Mar;22(3):95-115. doi: 10.1007/s11892-022-01453-4. Epub 2022 Mar 10.
Zotero 插件